The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.75

Today's change0.00 0.00%
Updated July 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.75

Today's change0.00 0.00%
Updated July 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Harvard Bioscience Inc closed at (U.S.)$2.75.

Over the last five days, shares have gained 10.00%, but are down 9.84% for the last year to date. Shares have underperformed the S&P 500 by 22.28% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $2.75
  • High--
  • Low--
  • Bid / Ask(U.S.) $2.30 / (U.S.) $0.00
  • YTD % change-9.84%
  • Volume0
  • Average volume (10-day)54,923
  • Average volume (1-month)53,951
  • Average volume (3-month)77,218
  • 52-week range(U.S.) $2.25 to (U.S.) $3.30
  • Beta1.17
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.94×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.14
Updated July 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue24262526
Total other revenue--------
Total revenue24262526
Gross profit11121212
Total cost of revenue13141314
Total operating expense25282627
Selling / general / administrative10101010
Research & development1112
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)0110
Other operating expenses, total--------
Operating income-1-1-1-1
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-1-1-1
Income after tax-1-1-2-1
Income tax, total0010
Net income-1-1-2-1
Total adjustments to net income--------
Net income before extra. items-1-1-2-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-1-2-1
Inc. avail. to common incl. extra. items-1-1-2-1
Diluted net income-1-1-2-1
Dilution adjustment--------
Diluted weighted average shares35343434
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.04-0.05-0.02
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.03-0.02-0.04-0.02